Cagrilintide 10mg – Synthetic Research Peptide
Cagrilintide is a synthetic, long-acting analog of human amylin, a pancreatic peptide hormone involved in glucose regulation and satiety signaling. Structural modifications, including fatty acid acylation and amino acid substitutions, extend its half-life relative to native amylin, allowing sustained receptor engagement in experimental models. A growing body of endocrinology and metabolic research literature has examined this compound.
Each vial ships with 10mg of lyophilized Cagrilintide sealed in a 3mL glass vial, backed by Phantom Peptides’ internal verification standard: independent third-party lab analysis.
Product Specifications
- Compound: Cagrilintide
- Class: Synthetic long-acting amylin analog
- Molecular Weight: ~3,489 Da
- Form: Lyophilized powder
- Vial Size: 10mg / 3mL glass vial
- Purity: 99%+, confirmed via HPLC and mass spec (COAs available)
Research Background
The existing literature on cagrilintide spans a handful of distinct research threads:
- Amylin receptor pharmacology: binding and activation studies characterizing cagrilintide’s interaction with amylin and calcitonin receptor complexes
- Satiety and food intake research: animal models examining the peptide’s effects on appetite signaling and caloric intake regulation
- Glucose homeostasis research: metabolic studies looking at downstream effects on insulin sensitivity and glycemic control
- Pharmacokinetic research: half-life and degradation studies comparing acylated amylin analogs against native amylin
- Comparative peptide research: cagrilintide examined alongside other amylin and incretin-based research peptides in preclinical models
Development traces back to amylin-analog research programs within the peptide therapeutics field, with the deepest body of published work coming out of academic and industry-affiliated metabolic disease research groups. For primary sources, PubMed (pubmed.ncbi.nlm.nih.gov) and NIH’s PMC database (pmc.ncbi.nlm.nih.gov) index the peer reviewed literature on cagrilintide and amylin analog research.
